vs
Antero Midstream Corp（AM）与Ascendis Pharma A/S（ASND）财务数据对比。点击上方公司名可切换其他公司
Antero Midstream Corp的季度营收约是Ascendis Pharma A/S的1.1倍（$291.1M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs -7.3%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 3.9%）
Antero Midstream Corp是美国能源企业，注册地为特拉华州，总部设于科罗拉多州丹佛市。公司全部油气储量均位于阿巴拉契亚盆地，采用水力压裂技术开采，核心业务涵盖油气勘探开发相关领域。
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
AM vs ASND — 直观对比
营收规模更大
AM
是对方的1.1倍
$267.3M
营收增速更快
ASND
高出49.7%
-7.3%
两年增速更快
ASND
近两年复合增速
3.9%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $291.1M | $267.3M |
| 净利润 | $120.7M | — |
| 毛利率 | — | 90.5% |
| 营业利润率 | 60.9% | — |
| 净利率 | 41.5% | — |
| 营收同比 | -7.3% | 42.3% |
| 净利润同比 | 2.1% | — |
| 每股收益（稀释后） | $0.25 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMASND
| Q1 26 | $291.1M | — | ||
| Q4 25 | $297.0M | $267.3M | ||
| Q3 25 | $294.8M | $230.7M | ||
| Q2 25 | $305.5M | $170.7M | ||
| Q1 25 | $291.1M | $109.0M | ||
| Q4 24 | $287.5M | $187.8M | ||
| Q3 24 | $269.9M | $62.5M | ||
| Q2 24 | $269.8M | $38.9M |
净利润AMASND
| Q1 26 | $120.7M | — | ||
| Q4 25 | $51.9M | — | ||
| Q3 25 | $116.0M | $-65.9M | ||
| Q2 25 | $124.5M | $-42.0M | ||
| Q1 25 | $120.7M | $-102.2M | ||
| Q4 24 | $111.2M | — | ||
| Q3 24 | $99.7M | $-107.1M | ||
| Q2 24 | $86.0M | $-118.1M |
毛利率AMASND
| Q1 26 | — | — | ||
| Q4 25 | — | 90.5% | ||
| Q3 25 | — | 89.5% | ||
| Q2 25 | — | 80.1% | ||
| Q1 25 | — | 82.6% | ||
| Q4 24 | — | 91.9% | ||
| Q3 24 | — | 80.6% | ||
| Q2 24 | — | 68.2% |
营业利润率AMASND
| Q1 26 | 60.9% | — | ||
| Q4 25 | 33.8% | — | ||
| Q3 25 | 61.2% | 5.1% | ||
| Q2 25 | 61.0% | -33.5% | ||
| Q1 25 | 60.9% | -103.2% | ||
| Q4 24 | 61.8% | — | ||
| Q3 24 | 60.2% | -167.3% | ||
| Q2 24 | 56.6% | -370.2% |
净利率AMASND
| Q1 26 | 41.5% | — | ||
| Q4 25 | 17.5% | — | ||
| Q3 25 | 39.3% | -28.5% | ||
| Q2 25 | 40.8% | -24.6% | ||
| Q1 25 | 41.5% | -93.7% | ||
| Q4 24 | 38.7% | — | ||
| Q3 24 | 37.0% | -171.5% | ||
| Q2 24 | 31.9% | -303.9% |
每股收益（稀释后）AMASND
| Q1 26 | $0.25 | — | ||
| Q4 25 | $0.11 | — | ||
| Q3 25 | $0.24 | — | ||
| Q2 25 | $0.26 | — | ||
| Q1 25 | $0.25 | — | ||
| Q4 24 | $0.23 | — | ||
| Q3 24 | $0.21 | — | ||
| Q2 24 | $0.18 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $180.4M | $665.3M |
| 总债务越低越好 | $3.2B | — |
| 股东权益账面价值 | $2.0B | $-175.8M |
| 总资产 | $5.9B | $1.4B |
| 负债/权益比越低杠杆越低 | 1.63× | — |
8季度趋势，按日历期对齐
现金及短期投资AMASND
| Q1 26 | $180.4M | — | ||
| Q4 25 | $180.4M | $665.3M | ||
| Q3 25 | — | $582.2M | ||
| Q2 25 | — | $533.6M | ||
| Q1 25 | — | $559.4M | ||
| Q4 24 | — | $604.3M | ||
| Q3 24 | — | $675.6M | ||
| Q2 24 | — | $279.4M |
总债务AMASND
| Q1 26 | $3.2B | — | ||
| Q4 25 | $3.2B | — | ||
| Q3 25 | $3.0B | — | ||
| Q2 25 | $3.0B | — | ||
| Q1 25 | $3.1B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.2B | — | ||
| Q2 24 | $3.2B | — |
股东权益AMASND
| Q1 26 | $2.0B | — | ||
| Q4 25 | $2.0B | $-175.8M | ||
| Q3 25 | $2.1B | $-188.0M | ||
| Q2 25 | $2.1B | $-202.6M | ||
| Q1 25 | $2.1B | $-205.0M | ||
| Q4 24 | $2.1B | $-114.2M | ||
| Q3 24 | $2.1B | $-105.1M | ||
| Q2 24 | $2.1B | $-346.8M |
总资产AMASND
| Q1 26 | $5.9B | — | ||
| Q4 25 | $5.9B | $1.4B | ||
| Q3 25 | $5.7B | $1.2B | ||
| Q2 25 | $5.7B | $1.2B | ||
| Q1 25 | $5.8B | $1.1B | ||
| Q4 24 | $5.8B | $1.3B | ||
| Q3 24 | $5.8B | $1.2B | ||
| Q2 24 | $5.8B | $819.0M |
负债/权益比AMASND
| Q1 26 | 1.63× | — | ||
| Q4 25 | 1.63× | — | ||
| Q3 25 | 1.46× | — | ||
| Q2 25 | 1.45× | — | ||
| Q1 25 | 1.49× | — | ||
| Q4 24 | 1.47× | — | ||
| Q3 24 | 1.49× | — | ||
| Q2 24 | 1.50× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $198.9M | $58.2M |
| 自由现金流经营现金流 - 资本支出 | $186.9M | — |
| 自由现金流率自由现金流/营收 | 64.2% | — |
| 资本支出强度资本支出/营收 | 11.1% | — |
| 现金转化率经营现金流/净利润 | 1.65× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流AMASND
| Q1 26 | $198.9M | — | ||
| Q4 25 | $255.5M | $58.2M | ||
| Q3 25 | $212.8M | — | ||
| Q2 25 | $265.2M | — | ||
| Q1 25 | $198.9M | $-15.5M | ||
| Q4 24 | $232.7M | $-330.7M | ||
| Q3 24 | $184.9M | — | ||
| Q2 24 | $215.8M | — |
自由现金流AMASND
| Q1 26 | $186.9M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $184.3M | — | ||
| Q2 24 | $147.2M | — |
自由现金流率AMASND
| Q1 26 | 64.2% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 68.3% | — | ||
| Q2 24 | 54.6% | — |
资本支出强度AMASND
| Q1 26 | 11.1% | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 0.0% | — | ||
| Q3 24 | 0.2% | — | ||
| Q2 24 | 25.4% | — |
现金转化率AMASND
| Q1 26 | 1.65× | — | ||
| Q4 25 | 4.92× | — | ||
| Q3 25 | 1.84× | — | ||
| Q2 25 | 2.13× | — | ||
| Q1 25 | 1.65× | — | ||
| Q4 24 | 2.09× | — | ||
| Q3 24 | 1.85× | — | ||
| Q2 24 | 2.51× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AM
| Gathering and compression–Antero Resources | $238.0M | 82% |
| Other | $52.3M | 18% |
| Water handling–third party | $505.0K | 0% |
| Gathering and compression–third party | $295.0K | 0% |
ASND
暂无分部数据
